-
In talking about understanding the reasons for errors in the effort to support higher reliability, Marty B. Scott, MD, MBA, VP, quality and patient safety at Memorial Health University Medical Center in Savannah, GA, points to James Reason's swiss cheese model, proposed in 1990.
-
Currently, core measure data are used "in the context of a variety of processes here at The Joint Commission" including in public reporting and the priority focus process, says Jerob Loeb, PhD, The Joint Commission's vice president, division of quality measurement and research.
-
It's not all about liability when it comes to admitting medical mistakes, and it's not all about the increase or decrease of lawsuits and, thus, costs.
-
The American College of Emergency Physicians (ACEP) has three "low-cost, high-impact" solutions to boarding, says Sandra M. Schneider, MD, FACEP, president-elect of ACEP; professor of emergency medicine at University of Rochester (NY) Medical Center; and a physician at Strong Memorial Hospital, also in Rochester.
-
A lot of hospitals are doing it these days posting their emergency department wait times on bulletin boards, on their websites, or even through text messages.
-
In May, the Centers for Medicare & Medicaid Services (CMS) issued transmittal 59, clarifying the interpretative guidelines for the anesthesia services Conditions of Participation, the latest in a round of changes in the arena of anesthesiology.
-
Accountability. It's an oft-heard word these days in health care. But just what is accountability? The Joint Commission is setting out to turn the buzzword into something more meaningful, more definable with distinct criteria.
-
Although the law is squarely on the side of the pregnant mother in maternal-fetal conflict, the ethics should be examined to determine how one reaches that conclusion, according to Mark R. Mercurio, MD, MA, a neonatologist at the Yale-New Haven (CT) Children's Hospital and director of the Yale Pediatric Ethics Program.
-
Women with fibromyalgia participated in a treatment protocol consisting of an educational consultation with a physician, followed by group activities focusing on structured written emotional disclosure and emotional awareness exercises. The treatment group was compared to a wait-list control group of fibromyalgia patients. The affective self-awareness (ASA) intervention significantly improved pain, tenderness, and physical function for at least 6 months in the treatment group compared to the wait-list control group.
-
Lorcaserin submitted for FDA review, FDA advisory panel votes against phentermine/topiramate, mixed vote on rosiglitazone, advisory panel votes to remove breast cancer indication from bevacizumab labeling, no increase in seizures found with DTaP vaccine, new REMS for quinine.
